Evidence map›Paper›PMID 31530277›Full record

ArticleJournal of nanobiotechnology2019

Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs.

Philipp Nold, Raimo Hartmann, Neus Feliu, Karsten Kantner, Mahmoud Gamal, Beatriz Pelaz, Jonas Hühn, Xing Sun, Philipp Jungebluth, Pablo Del Pino and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Philipp NoldDepartment of Hematology, Oncology and Immunology, Philipps University Marburg, Marburg, Germany.
Raimo HartmannDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Neus FeliuDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Karsten KantnerDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Mahmoud GamalDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Beatriz PelazDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Jonas HühnDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Xing SunDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Philipp JungebluthThoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
Pablo Del PinoDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Holger HacksteinInstitute for Clinical Immunology and Transfusion Medicine, Justus-Liebig University Giessen, Giessen, Germany.
Paolo MacchiariniLaboratory of Bioengineering & Regenerative Medicine (BioReM), Kazan Federal University, Kazan, Russia.
Wolfgang J ParakDepartment of Physics, Philipps-University of Marburg, Marburg, Germany. wolfgang.parak@physik.uni-marburg.de.
Cornelia BrendelDepartment of Hematology, Oncology and Immunology, Philipps University Marburg, Marburg, Germany. brendelc@staff.uni-marburg.de.ORCID http://orcid.org/0000-0003-1612-9557

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors apologized for the unfortunate error in figure during publication of the article and they also explained that some of the solid grey graphs in Fig. 5 are intentionally based on the same data. For 8 different surface makers (CD14, CD73, CD34, CD105, CD19, CD90, CD45, HA-DR) in accordance to the guidelines of the manufacturer a panel of 4 different isotype controls were used, corresponding to 4 different fluorescence channels.

Identifiers

PMID31530277
PMCPMC6749620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.